TERT promoter hypermethylation in gastrointestinal cancer: A potential stool biomarker
The Oncologist Aug 11, 2017
Liu L, et al. – This study was meant to gauge telomerase reverse transcriptase gene (TERT) promoter methylation in fecal samples from gastrointestinal cancer (GIC) patients and healthy adults, and its value as a stool biomarker for GIC detection was examined. In view of the outcomes, stool TERT promoter methylation was feasible as an additional tool in noninvasive GIC screening.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
